Mohamad Mohty MD, PhD

Dr. Mohamad Mohty is Professor of Hematology and head of the Hematology and cellular therapy Department at the Saint-Antoine Hospital and Sorbonne University (Paris, France). This department is one of the largest hematology departments in France and Europe, including more than 200 members of staff.
His research is focused on the role of key immune effectors in hematologic diseases and their interactions with novel immune and cellular therapies in the treatment of hematologic malignancies. He has strong expertise in clinical research and deep knowledge in the field of stem cell transplantation, and therapy of leukemia and multiple myeloma. Over the last 15 years, he has played a key role in the approval of different hematology drugs.
Pr Mohty has always been driven by a strong entrepreneurial and innovative spirit, and is currently involved in deciphering new frontiers in hematology, especially the role of microbiome restoration therapy using biotherapeutics, made of a highly diverse microbiome, to treat blood cancers.
Pr Mohty has a large worldwide network for cooperation and collaboration in hematology. He is a past-president of the European Society for Blood and Marrow Transplantation and the current chairman of the Acute Leukemia Working Party of EBMT. He is also the founder and chairman of the “International Academy for Clinical Hematology (IACH; http://www.iach.org/). He also serves on the board of the “Intergroupe Francophone du Myelome” (IFM). 
Pr Mohty has edited and co-authored many book chapters and published more than 1150 peer-reviewed articles in the field of stem cell transplantation, leukemia, lymphoma, and myeloma. He also serves as Editor-in-Chief of the journals Bone Marrow Transplantation and Clinical Hematology International, as Associate Editor for Leukemia, European Journal of Haematology, and Blood Cancer Journal, and as a member of the editorial board of Haematologica.